NeuroSense Therapeutics Q2'26 EPS seen at (0.20) USD
NeuroSense Therapeutics Ltd. is set to announce Q2'26 results on September 02. The Q2'26 revenue estimate is 0 USD, with EPS anticipated at (0.20) USD.
NRSN (NeuroSense Therapeutics Ltd.) is set to announce its Q2'26 results on September 02, time not specified.
The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.20) USD.
Learn more details at NR…